Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Nicotinamide N-oxide
Cat. No.:
0225LY-1148
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
Nicotinamide N-oxide is an in vitvo metabolite of nicotinamide and a precursor to NAD+, which is reduced back to nicotinamide in the liver by xanthine oxidase.
Synonym:
Nicotinamide-N-oxide; Nicotinamide 1-oxide; 1-oxynicotinamide; 1986-81-8; Nicotinamide-n-oxide; 3-Pyridinecarboxamide, 1-oxide; 1-oxidopyridin-1-ium-3-carboxamide; 3-carbamoylpyridin-1-ium-1-olate; 1-Oxy-nicotinamide; 3-Carbamoylpyridine 1-oxide; Nicotinamide, 1-oxide; Nicotinamide N1-oxide; Oxynicotinamide; 1-Oxide-nicotinamide
CAS No.:
1986-81-8
Compound CID:
72661
Formula:
C6H6N2O2
Formula Weight:
138.12
Specification
Relative Density:
1.34 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Nicotinamide N-oxide can be used in metabolic studies to examine the oxidation products of nicotinamide and their biological relevance.
Library Information
Target:
CXCR; c-Myc
Receptor:
c-Myc; CXCR
Pathways:
Autophagy; Metabolism; Cell cycle/Checkpoint; GPCR/G protein signaling; Immunology/Inflammation
Plate Number:
AOCL-15
Plate Location:
g4
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
3.85 mg/mL; 27.87 mM
